Cardio-Oncology Unit

What does the Unit treat?

At HM CIOCC, our Cardio-Oncology Unit is dedicated to protecting the cardiovascular health of cancer patients. We understand that oncological treatments can have side effects on the heart, and therefore we offer a comprehensive approach to the prevention, early detection, and management of cardiotoxicity.

What makes us different?

• Pioneering Unit in Spain: We are one of the first specialized cardio-oncology units in Spain, with extensive experience in the cardiovascular protection of oncology patients.
• Comprehensive and personalized approach: We adapt our protocols to each patient, considering their type of cancer, oncological treatment, and cardiovascular history.
• Advanced cardiac imaging technology: We use techniques such as cardiac magnetic resonance imaging with MyoStrain to detect cardiotoxicity early and guide treatment.
• Close collaboration with oncologists: We work as a team with oncologists to optimize oncological treatments and minimize cardiovascular risks.

Related Diseases

All types of cancer where treatment can cause cardiotoxicity, including:

• Breast cancer (trastuzumab, anthracyclines).
• Lymphomas (anthracyclines).
• Leukemias (anthracyclines).
• Sarcomas (anthracyclines).
• Etc.

Cardiovascular conditions that can be intensified with cancer treatment, including:

• Heart failure.
• Arrhythmias.
• Ischemic heart disease.
• Hypertension.
• Valvular heart disease.

Who is it for?

• Cancer patients who are about to start or are already undergoing treatment with chemotherapy, radiotherapy, or targeted therapies.
• Cancer patients with pre-existing cardiovascular conditions.
• Cancer survivors with a history of cardiotoxicity.
• People at high risk of developing cancer who wish to proactively manage their cardiovascular health.

What do we offer?

• Complete cardiological evaluation: We perform a comprehensive evaluation before, during, and after oncological treatment to identify risk factors and detect signs of cardiotoxicity.
• Continuous monitoring: Close monitoring of cardiac function during oncological treatment to detect any alteration early.
• Individualized treatment: We adapt cardiological treatment to the needs of each patient, using cardioprotective drugs and other strategies to minimize the side effects of oncological treatment.
• Cardiac rehabilitation: We offer cardiac rehabilitation programs to improve cardiac function and quality of life for patients who have suffered cardiotoxicity.